COVID-19 Impact on Global COPD Drug Delivery Devices Market Insights, Forecast to 2026
COPD Drug Delivery Devices market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global COPD Drug Delivery Devices market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on production capacity, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the COPD Drug Delivery Devices market is segmented into
The COPD Drug Delivery Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the COPD Drug Delivery Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and COPD Drug Delivery Devices Market Share Analysis
COPD Drug Delivery Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of COPD Drug Delivery Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in COPD Drug Delivery Devices business, the date to enter into the COPD Drug Delivery Devices market, COPD Drug Delivery Devices product introduction, recent developments, etc.
The major vendors covered:
Segment by Type, the COPD Drug Delivery Devices market is segmented into
- MDI
- DPI
- Hospital
- Clinic
- Others
The COPD Drug Delivery Devices market is analysed and market size information is provided by regions (countries).
The key regions covered in the COPD Drug Delivery Devices market report are North America, Europe, China and Japan. It also covers key regions (countries), viz, the U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of production capacity, price and revenue for the period 2015-2026.
Competitive Landscape and COPD Drug Delivery Devices Market Share Analysis
COPD Drug Delivery Devices market competitive landscape provides details and data information by manufacturers. The report offers comprehensive analysis and accurate statistics on production capacity, price, revenue of COPD Drug Delivery Devices by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on production, revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue, and the production capacity, price, revenue generated in COPD Drug Delivery Devices business, the date to enter into the COPD Drug Delivery Devices market, COPD Drug Delivery Devices product introduction, recent developments, etc.
The major vendors covered:
- AstraZeneca
- Boehringer Ingelheim GmbH
- GlaxoSmithKline plc
- Novartis AG
- Teva Pharmaceutical Industries
- Merck & Co., Inc.
- Sunovion Pharmaceuticals, Inc.
- Koninklijke Philips
- Omron Corporation
- Cipla Inc.
1 STUDY COVERAGE
1.1 COPD Drug Delivery Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top COPD Drug Delivery Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global COPD Drug Delivery Devices Market Size Growth Rate by Type
1.4.2 MDI
1.4.3 DPI
1.5 Market by Application
1.5.1 Global COPD Drug Delivery Devices Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): COPD Drug Delivery Devices Industry Impact
1.6.1 How the Covid-19 is Affecting the COPD Drug Delivery Devices Industry
1.6.1.1 COPD Drug Delivery Devices Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and COPD Drug Delivery Devices Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for COPD Drug Delivery Devices Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global COPD Drug Delivery Devices Market Size Estimates and Forecasts
2.1.1 Global COPD Drug Delivery Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global COPD Drug Delivery Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global COPD Drug Delivery Devices Production Estimates and Forecasts 2015-2026
2.2 Global COPD Drug Delivery Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global COPD Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global COPD Drug Delivery Devices Manufacturers Geographical Distribution
2.4 Key Trends for COPD Drug Delivery Devices Markets & Products
2.5 Primary Interviews with Key COPD Drug Delivery Devices Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top COPD Drug Delivery Devices Manufacturers by Production Capacity
3.1.1 Global Top COPD Drug Delivery Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top COPD Drug Delivery Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top COPD Drug Delivery Devices Manufacturers Market Share by Production
3.2 Global Top COPD Drug Delivery Devices Manufacturers by Revenue
3.2.1 Global Top COPD Drug Delivery Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top COPD Drug Delivery Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by COPD Drug Delivery Devices Revenue in 2019
3.3 Global COPD Drug Delivery Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 COPD DRUG DELIVERY DEVICES PRODUCTION BY REGIONS
4.1 Global COPD Drug Delivery Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top COPD Drug Delivery Devices Regions by Production (2015-2020)
4.1.2 Global Top COPD Drug Delivery Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America COPD Drug Delivery Devices Production (2015-2020)
4.2.2 North America COPD Drug Delivery Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America COPD Drug Delivery Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe COPD Drug Delivery Devices Production (2015-2020)
4.3.2 Europe COPD Drug Delivery Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe COPD Drug Delivery Devices Import & Export (2015-2020)
4.4 China
4.4.1 China COPD Drug Delivery Devices Production (2015-2020)
4.4.2 China COPD Drug Delivery Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China COPD Drug Delivery Devices Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan COPD Drug Delivery Devices Production (2015-2020)
4.5.2 Japan COPD Drug Delivery Devices Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan COPD Drug Delivery Devices Import & Export (2015-2020)
5 COPD DRUG DELIVERY DEVICES CONSUMPTION BY REGION
5.1 Global Top COPD Drug Delivery Devices Regions by Consumption
5.1.1 Global Top COPD Drug Delivery Devices Regions by Consumption (2015-2020)
5.1.2 Global Top COPD Drug Delivery Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America COPD Drug Delivery Devices Consumption by Application
5.2.2 North America COPD Drug Delivery Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe COPD Drug Delivery Devices Consumption by Application
5.3.2 Europe COPD Drug Delivery Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific COPD Drug Delivery Devices Consumption by Application
5.4.2 Asia Pacific COPD Drug Delivery Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America COPD Drug Delivery Devices Consumption by Application
5.5.2 Central & South America COPD Drug Delivery Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa COPD Drug Delivery Devices Consumption by Application
5.6.2 Middle East and Africa COPD Drug Delivery Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global COPD Drug Delivery Devices Market Size by Type (2015-2020)
6.1.1 Global COPD Drug Delivery Devices Production by Type (2015-2020)
6.1.2 Global COPD Drug Delivery Devices Revenue by Type (2015-2020)
6.1.3 COPD Drug Delivery Devices Price by Type (2015-2020)
6.2 Global COPD Drug Delivery Devices Market Forecast by Type (2021-2026)
6.2.1 Global COPD Drug Delivery Devices Production Forecast by Type (2021-2026)
6.2.2 Global COPD Drug Delivery Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global COPD Drug Delivery Devices Price Forecast by Type (2021-2026)
6.3 Global COPD Drug Delivery Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global COPD Drug Delivery Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global COPD Drug Delivery Devices Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 AstraZeneca
8.1.1 AstraZeneca Corporation Information
8.1.2 AstraZeneca Overview and Its Total Revenue
8.1.3 AstraZeneca Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 AstraZeneca Product Description
8.1.5 AstraZeneca Recent Development
8.2 Boehringer Ingelheim GmbH
8.2.1 Boehringer Ingelheim GmbH Corporation Information
8.2.2 Boehringer Ingelheim GmbH Overview and Its Total Revenue
8.2.3 Boehringer Ingelheim GmbH Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Boehringer Ingelheim GmbH Product Description
8.2.5 Boehringer Ingelheim GmbH Recent Development
8.3 GlaxoSmithKline plc
8.3.1 GlaxoSmithKline plc Corporation Information
8.3.2 GlaxoSmithKline plc Overview and Its Total Revenue
8.3.3 GlaxoSmithKline plc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 GlaxoSmithKline plc Product Description
8.3.5 GlaxoSmithKline plc Recent Development
8.4 Novartis AG
8.4.1 Novartis AG Corporation Information
8.4.2 Novartis AG Overview and Its Total Revenue
8.4.3 Novartis AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Novartis AG Product Description
8.4.5 Novartis AG Recent Development
8.5 Teva Pharmaceutical Industries
8.5.1 Teva Pharmaceutical Industries Corporation Information
8.5.2 Teva Pharmaceutical Industries Overview and Its Total Revenue
8.5.3 Teva Pharmaceutical Industries Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Teva Pharmaceutical Industries Product Description
8.5.5 Teva Pharmaceutical Industries Recent Development
8.6 Merck & Co., Inc.
8.6.1 Merck & Co., Inc. Corporation Information
8.6.2 Merck & Co., Inc. Overview and Its Total Revenue
8.6.3 Merck & Co., Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Merck & Co., Inc. Product Description
8.6.5 Merck & Co., Inc. Recent Development
8.7 Sunovion Pharmaceuticals, Inc.
8.7.1 Sunovion Pharmaceuticals, Inc. Corporation Information
8.7.2 Sunovion Pharmaceuticals, Inc. Overview and Its Total Revenue
8.7.3 Sunovion Pharmaceuticals, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Sunovion Pharmaceuticals, Inc. Product Description
8.7.5 Sunovion Pharmaceuticals, Inc. Recent Development
8.8 Koninklijke Philips
8.8.1 Koninklijke Philips Corporation Information
8.8.2 Koninklijke Philips Overview and Its Total Revenue
8.8.3 Koninklijke Philips Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Koninklijke Philips Product Description
8.8.5 Koninklijke Philips Recent Development
8.9 Omron Corporation
8.9.1 Omron Corporation Corporation Information
8.9.2 Omron Corporation Overview and Its Total Revenue
8.9.3 Omron Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Omron Corporation Product Description
8.9.5 Omron Corporation Recent Development
8.10 Cipla Inc.
8.10.1 Cipla Inc. Corporation Information
8.10.2 Cipla Inc. Overview and Its Total Revenue
8.10.3 Cipla Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Cipla Inc. Product Description
8.10.5 Cipla Inc. Recent Development
8.11 PARI GmbH
8.11.1 PARI GmbH Corporation Information
8.11.2 PARI GmbH Overview and Its Total Revenue
8.11.3 PARI GmbH Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 PARI GmbH Product Description
8.11.5 PARI GmbH Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top COPD Drug Delivery Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top COPD Drug Delivery Devices Regions Forecast by Production (2021-2026)
9.3 Key COPD Drug Delivery Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 COPD DRUG DELIVERY DEVICES CONSUMPTION FORECAST BY REGION
10.1 Global COPD Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.2 North America COPD Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.3 Europe COPD Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific COPD Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America COPD Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa COPD Drug Delivery Devices Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 COPD Drug Delivery Devices Sales Channels
11.2.2 COPD Drug Delivery Devices Distributors
11.3 COPD Drug Delivery Devices Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL COPD DRUG DELIVERY DEVICES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
1.1 COPD Drug Delivery Devices Product Introduction
1.2 Key Market Segments in This Study
1.3 Key Manufacturers Covered: Ranking of Global Top COPD Drug Delivery Devices Manufacturers by Revenue in 2019
1.4 Market by Type
1.4.1 Global COPD Drug Delivery Devices Market Size Growth Rate by Type
1.4.2 MDI
1.4.3 DPI
1.5 Market by Application
1.5.1 Global COPD Drug Delivery Devices Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Others
1.6 Coronavirus Disease 2019 (Covid-19): COPD Drug Delivery Devices Industry Impact
1.6.1 How the Covid-19 is Affecting the COPD Drug Delivery Devices Industry
1.6.1.1 COPD Drug Delivery Devices Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and COPD Drug Delivery Devices Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for COPD Drug Delivery Devices Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 EXECUTIVE SUMMARY
2.1 Global COPD Drug Delivery Devices Market Size Estimates and Forecasts
2.1.1 Global COPD Drug Delivery Devices Revenue Estimates and Forecasts 2015-2026
2.1.2 Global COPD Drug Delivery Devices Production Capacity Estimates and Forecasts 2015-2026
2.1.3 Global COPD Drug Delivery Devices Production Estimates and Forecasts 2015-2026
2.2 Global COPD Drug Delivery Devices Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.3 Analysis of Competitive Landscape
2.3.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
2.3.2 Global COPD Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.3.3 Global COPD Drug Delivery Devices Manufacturers Geographical Distribution
2.4 Key Trends for COPD Drug Delivery Devices Markets & Products
2.5 Primary Interviews with Key COPD Drug Delivery Devices Players (Opinion Leaders)
3 MARKET SIZE BY MANUFACTURERS
3.1 Global Top COPD Drug Delivery Devices Manufacturers by Production Capacity
3.1.1 Global Top COPD Drug Delivery Devices Manufacturers by Production Capacity (2015-2020)
3.1.2 Global Top COPD Drug Delivery Devices Manufacturers by Production (2015-2020)
3.1.3 Global Top COPD Drug Delivery Devices Manufacturers Market Share by Production
3.2 Global Top COPD Drug Delivery Devices Manufacturers by Revenue
3.2.1 Global Top COPD Drug Delivery Devices Manufacturers by Revenue (2015-2020)
3.2.2 Global Top COPD Drug Delivery Devices Manufacturers Market Share by Revenue (2015-2020)
3.2.3 Global Top 10 and Top 5 Companies by COPD Drug Delivery Devices Revenue in 2019
3.3 Global COPD Drug Delivery Devices Price by Manufacturers
3.4 Mergers & Acquisitions, Expansion Plans
4 COPD DRUG DELIVERY DEVICES PRODUCTION BY REGIONS
4.1 Global COPD Drug Delivery Devices Historic Market Facts & Figures by Regions
4.1.1 Global Top COPD Drug Delivery Devices Regions by Production (2015-2020)
4.1.2 Global Top COPD Drug Delivery Devices Regions by Revenue (2015-2020)
4.2 North America
4.2.1 North America COPD Drug Delivery Devices Production (2015-2020)
4.2.2 North America COPD Drug Delivery Devices Revenue (2015-2020)
4.2.3 Key Players in North America
4.2.4 North America COPD Drug Delivery Devices Import & Export (2015-2020)
4.3 Europe
4.3.1 Europe COPD Drug Delivery Devices Production (2015-2020)
4.3.2 Europe COPD Drug Delivery Devices Revenue (2015-2020)
4.3.3 Key Players in Europe
4.3.4 Europe COPD Drug Delivery Devices Import & Export (2015-2020)
4.4 China
4.4.1 China COPD Drug Delivery Devices Production (2015-2020)
4.4.2 China COPD Drug Delivery Devices Revenue (2015-2020)
4.4.3 Key Players in China
4.4.4 China COPD Drug Delivery Devices Import & Export (2015-2020)
4.5 Japan
4.5.1 Japan COPD Drug Delivery Devices Production (2015-2020)
4.5.2 Japan COPD Drug Delivery Devices Revenue (2015-2020)
4.5.3 Key Players in Japan
4.5.4 Japan COPD Drug Delivery Devices Import & Export (2015-2020)
5 COPD DRUG DELIVERY DEVICES CONSUMPTION BY REGION
5.1 Global Top COPD Drug Delivery Devices Regions by Consumption
5.1.1 Global Top COPD Drug Delivery Devices Regions by Consumption (2015-2020)
5.1.2 Global Top COPD Drug Delivery Devices Regions Market Share by Consumption (2015-2020)
5.2 North America
5.2.1 North America COPD Drug Delivery Devices Consumption by Application
5.2.2 North America COPD Drug Delivery Devices Consumption by Countries
5.2.3 U.S.
5.2.4 Canada
5.3 Europe
5.3.1 Europe COPD Drug Delivery Devices Consumption by Application
5.3.2 Europe COPD Drug Delivery Devices Consumption by Countries
5.3.3 Germany
5.3.4 France
5.3.5 U.K.
5.3.6 Italy
5.3.7 Russia
5.4 Asia Pacific
5.4.1 Asia Pacific COPD Drug Delivery Devices Consumption by Application
5.4.2 Asia Pacific COPD Drug Delivery Devices Consumption by Regions
5.4.3 China
5.4.4 Japan
5.4.5 South Korea
5.4.6 India
5.4.7 Australia
5.4.8 Taiwan
5.4.9 Indonesia
5.4.10 Thailand
5.4.11 Malaysia
5.4.12 Philippines
5.4.13 Vietnam
5.5 Central & South America
5.5.1 Central & South America COPD Drug Delivery Devices Consumption by Application
5.5.2 Central & South America COPD Drug Delivery Devices Consumption by Country
5.5.3 Mexico
5.5.3 Brazil
5.5.3 Argentina
5.6 Middle East and Africa
5.6.1 Middle East and Africa COPD Drug Delivery Devices Consumption by Application
5.6.2 Middle East and Africa COPD Drug Delivery Devices Consumption by Countries
5.6.3 Turkey
5.6.4 Saudi Arabia
5.6.5 U.A.E
6 MARKET SIZE BY TYPE (2015-2026)
6.1 Global COPD Drug Delivery Devices Market Size by Type (2015-2020)
6.1.1 Global COPD Drug Delivery Devices Production by Type (2015-2020)
6.1.2 Global COPD Drug Delivery Devices Revenue by Type (2015-2020)
6.1.3 COPD Drug Delivery Devices Price by Type (2015-2020)
6.2 Global COPD Drug Delivery Devices Market Forecast by Type (2021-2026)
6.2.1 Global COPD Drug Delivery Devices Production Forecast by Type (2021-2026)
6.2.2 Global COPD Drug Delivery Devices Revenue Forecast by Type (2021-2026)
6.2.3 Global COPD Drug Delivery Devices Price Forecast by Type (2021-2026)
6.3 Global COPD Drug Delivery Devices Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
7 MARKET SIZE BY APPLICATION (2015-2026)
7.2.1 Global COPD Drug Delivery Devices Consumption Historic Breakdown by Application (2015-2020)
7.2.2 Global COPD Drug Delivery Devices Consumption Forecast by Application (2021-2026)
8 CORPORATE PROFILES
8.1 AstraZeneca
8.1.1 AstraZeneca Corporation Information
8.1.2 AstraZeneca Overview and Its Total Revenue
8.1.3 AstraZeneca Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.1.4 AstraZeneca Product Description
8.1.5 AstraZeneca Recent Development
8.2 Boehringer Ingelheim GmbH
8.2.1 Boehringer Ingelheim GmbH Corporation Information
8.2.2 Boehringer Ingelheim GmbH Overview and Its Total Revenue
8.2.3 Boehringer Ingelheim GmbH Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.2.4 Boehringer Ingelheim GmbH Product Description
8.2.5 Boehringer Ingelheim GmbH Recent Development
8.3 GlaxoSmithKline plc
8.3.1 GlaxoSmithKline plc Corporation Information
8.3.2 GlaxoSmithKline plc Overview and Its Total Revenue
8.3.3 GlaxoSmithKline plc Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.3.4 GlaxoSmithKline plc Product Description
8.3.5 GlaxoSmithKline plc Recent Development
8.4 Novartis AG
8.4.1 Novartis AG Corporation Information
8.4.2 Novartis AG Overview and Its Total Revenue
8.4.3 Novartis AG Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.4.4 Novartis AG Product Description
8.4.5 Novartis AG Recent Development
8.5 Teva Pharmaceutical Industries
8.5.1 Teva Pharmaceutical Industries Corporation Information
8.5.2 Teva Pharmaceutical Industries Overview and Its Total Revenue
8.5.3 Teva Pharmaceutical Industries Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.5.4 Teva Pharmaceutical Industries Product Description
8.5.5 Teva Pharmaceutical Industries Recent Development
8.6 Merck & Co., Inc.
8.6.1 Merck & Co., Inc. Corporation Information
8.6.2 Merck & Co., Inc. Overview and Its Total Revenue
8.6.3 Merck & Co., Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.6.4 Merck & Co., Inc. Product Description
8.6.5 Merck & Co., Inc. Recent Development
8.7 Sunovion Pharmaceuticals, Inc.
8.7.1 Sunovion Pharmaceuticals, Inc. Corporation Information
8.7.2 Sunovion Pharmaceuticals, Inc. Overview and Its Total Revenue
8.7.3 Sunovion Pharmaceuticals, Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.7.4 Sunovion Pharmaceuticals, Inc. Product Description
8.7.5 Sunovion Pharmaceuticals, Inc. Recent Development
8.8 Koninklijke Philips
8.8.1 Koninklijke Philips Corporation Information
8.8.2 Koninklijke Philips Overview and Its Total Revenue
8.8.3 Koninklijke Philips Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.8.4 Koninklijke Philips Product Description
8.8.5 Koninklijke Philips Recent Development
8.9 Omron Corporation
8.9.1 Omron Corporation Corporation Information
8.9.2 Omron Corporation Overview and Its Total Revenue
8.9.3 Omron Corporation Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.9.4 Omron Corporation Product Description
8.9.5 Omron Corporation Recent Development
8.10 Cipla Inc.
8.10.1 Cipla Inc. Corporation Information
8.10.2 Cipla Inc. Overview and Its Total Revenue
8.10.3 Cipla Inc. Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.10.4 Cipla Inc. Product Description
8.10.5 Cipla Inc. Recent Development
8.11 PARI GmbH
8.11.1 PARI GmbH Corporation Information
8.11.2 PARI GmbH Overview and Its Total Revenue
8.11.3 PARI GmbH Production Capacity and Supply, Price, Revenue and Gross Margin (2015-2020)
8.11.4 PARI GmbH Product Description
8.11.5 PARI GmbH Recent Development
9 PRODUCTION FORECASTS BY REGIONS
9.1 Global Top COPD Drug Delivery Devices Regions Forecast by Revenue (2021-2026)
9.2 Global Top COPD Drug Delivery Devices Regions Forecast by Production (2021-2026)
9.3 Key COPD Drug Delivery Devices Production Regions Forecast
9.3.1 North America
9.3.2 Europe
9.3.3 China
9.3.4 Japan
10 COPD DRUG DELIVERY DEVICES CONSUMPTION FORECAST BY REGION
10.1 Global COPD Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.2 North America COPD Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.3 Europe COPD Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.4 Asia Pacific COPD Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.5 Latin America COPD Drug Delivery Devices Consumption Forecast by Region (2021-2026)
10.6 Middle East and Africa COPD Drug Delivery Devices Consumption Forecast by Region (2021-2026)
11 VALUE CHAIN AND SALES CHANNELS ANALYSIS
11.1 Value Chain Analysis
11.2 Sales Channels Analysis
11.2.1 COPD Drug Delivery Devices Sales Channels
11.2.2 COPD Drug Delivery Devices Distributors
11.3 COPD Drug Delivery Devices Customers
12 MARKET OPPORTUNITIES & CHALLENGES, RISKS AND INFLUENCES FACTORS ANALYSIS
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Porter's Five Forces Analysis
13 KEY FINDING IN THE GLOBAL COPD DRUG DELIVERY DEVICES STUDY
14 APPENDIX
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
LIST OF TABLES
Table 1. COPD Drug Delivery Devices Key Market Segments in This Study
Table 2. Ranking of Global Top COPD Drug Delivery Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global COPD Drug Delivery Devices Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of MDI
Table 5. Major Manufacturers of DPI
Table 6. COVID-19 Impact Global Market: (Four COPD Drug Delivery Devices Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for COPD Drug Delivery Devices Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for COPD Drug Delivery Devices Players to Combat Covid-19 Impact
Table 11. Global COPD Drug Delivery Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global COPD Drug Delivery Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global COPD Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Drug Delivery Devices as of 2019)
Table 15. COPD Drug Delivery Devices Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers COPD Drug Delivery Devices Product Offered
Table 17. Date of Manufacturers Enter into COPD Drug Delivery Devices Market
Table 18. Key Trends for COPD Drug Delivery Devices Markets & Products
Table 19. Main Points Interviewed from Key COPD Drug Delivery Devices Players
Table 20. Global COPD Drug Delivery Devices Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global COPD Drug Delivery Devices Production Share by Manufacturers (2015-2020)
Table 22. COPD Drug Delivery Devices Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. COPD Drug Delivery Devices Revenue Share by Manufacturers (2015-2020)
Table 24. COPD Drug Delivery Devices Price by Manufacturers 2015-2020 (US$/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global COPD Drug Delivery Devices Production by Regions (2015-2020) (K Units)
Table 27. Global COPD Drug Delivery Devices Production Market Share by Regions (2015-2020)
Table 28. Global COPD Drug Delivery Devices Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global COPD Drug Delivery Devices Revenue Market Share by Regions (2015-2020)
Table 30. Key COPD Drug Delivery Devices Players in North America
Table 31. Import & Export of COPD Drug Delivery Devices in North America (K Units)
Table 32. Key COPD Drug Delivery Devices Players in Europe
Table 33. Import & Export of COPD Drug Delivery Devices in Europe (K Units)
Table 34. Key COPD Drug Delivery Devices Players in China
Table 35. Import & Export of COPD Drug Delivery Devices in China (K Units)
Table 36. Key COPD Drug Delivery Devices Players in Japan
Table 37. Import & Export of COPD Drug Delivery Devices in Japan (K Units)
Table 38. Global COPD Drug Delivery Devices Consumption by Regions (2015-2020) (K Units)
Table 39. Global COPD Drug Delivery Devices Consumption Market Share by Regions (2015-2020)
Table 40. North America COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 41. North America COPD Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 42. Europe COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 43. Europe COPD Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific COPD Drug Delivery Devices Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific COPD Drug Delivery Devices Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 48. Latin America COPD Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa COPD Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 51. Global COPD Drug Delivery Devices Production by Type (2015-2020) (K Units)
Table 52. Global COPD Drug Delivery Devices Production Share by Type (2015-2020)
Table 53. Global COPD Drug Delivery Devices Revenue by Type (2015-2020) (Million US$)
Table 54. Global COPD Drug Delivery Devices Revenue Share by Type (2015-2020)
Table 55. COPD Drug Delivery Devices Price by Type 2015-2020 (US$/Unit)
Table 56. Global COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 57. Global COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 58. Global COPD Drug Delivery Devices Consumption Share by Application (2015-2020)
Table 59. AstraZeneca Corporation Information
Table 60. AstraZeneca Description and Major Businesses
Table 61. AstraZeneca COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 62. AstraZeneca Product
Table 63. AstraZeneca Recent Development
Table 64. Boehringer Ingelheim GmbH Corporation Information
Table 65. Boehringer Ingelheim GmbH Description and Major Businesses
Table 66. Boehringer Ingelheim GmbH COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 67. Boehringer Ingelheim GmbH Product
Table 68. Boehringer Ingelheim GmbH Recent Development
Table 69. GlaxoSmithKline plc Corporation Information
Table 70. GlaxoSmithKline plc Description and Major Businesses
Table 71. GlaxoSmithKline plc COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 72. GlaxoSmithKline plc Product
Table 73. GlaxoSmithKline plc Recent Development
Table 74. Novartis AG Corporation Information
Table 75. Novartis AG Description and Major Businesses
Table 76. Novartis AG COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 77. Novartis AG Product
Table 78. Novartis AG Recent Development
Table 79. Teva Pharmaceutical Industries Corporation Information
Table 80. Teva Pharmaceutical Industries Description and Major Businesses
Table 81. Teva Pharmaceutical Industries COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 82. Teva Pharmaceutical Industries Product
Table 83. Teva Pharmaceutical Industries Recent Development
Table 84. Merck & Co., Inc. Corporation Information
Table 85. Merck & Co., Inc. Description and Major Businesses
Table 86. Merck & Co., Inc. COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 87. Merck & Co., Inc. Product
Table 88. Merck & Co., Inc. Recent Development
Table 89. Sunovion Pharmaceuticals, Inc. Corporation Information
Table 90. Sunovion Pharmaceuticals, Inc. Description and Major Businesses
Table 91. Sunovion Pharmaceuticals, Inc. COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 92. Sunovion Pharmaceuticals, Inc. Product
Table 93. Sunovion Pharmaceuticals, Inc. Recent Development
Table 94. Koninklijke Philips Corporation Information
Table 95. Koninklijke Philips Description and Major Businesses
Table 96. Koninklijke Philips COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 97. Koninklijke Philips Product
Table 98. Koninklijke Philips Recent Development
Table 99. Omron Corporation Corporation Information
Table 100. Omron Corporation Description and Major Businesses
Table 101. Omron Corporation COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 102. Omron Corporation Product
Table 103. Omron Corporation Recent Development
Table 104. Cipla Inc. Corporation Information
Table 105. Cipla Inc. Description and Major Businesses
Table 106. Cipla Inc. COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 107. Cipla Inc. Product
Table 108. Cipla Inc. Recent Development
Table 109. PARI GmbH Corporation Information
Table 110. PARI GmbH Description and Major Businesses
Table 111. PARI GmbH COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 112. PARI GmbH Product
Table 113. PARI GmbH Recent Development
Table 114. Global COPD Drug Delivery Devices Revenue Forecast by Region (2021-2026) (Million US$)
Table 115. Global COPD Drug Delivery Devices Production Forecast by Regions (2021-2026) (K Units)
Table 116. Global COPD Drug Delivery Devices Production Forecast by Type (2021-2026) (K Units)
Table 117. Global COPD Drug Delivery Devices Revenue Forecast by Type (2021-2026) (Million US$)
Table 118. North America COPD Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 119. Europe COPD Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 120. Asia Pacific COPD Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 121. Latin America COPD Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 122. Middle East and Africa COPD Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 123. COPD Drug Delivery Devices Distributors List
Table 124. COPD Drug Delivery Devices Customers List
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
Table 1. COPD Drug Delivery Devices Key Market Segments in This Study
Table 2. Ranking of Global Top COPD Drug Delivery Devices Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global COPD Drug Delivery Devices Market Size Growth Rate by Type 2020-2026 (K Units) (Million US$)
Table 4. Major Manufacturers of MDI
Table 5. Major Manufacturers of DPI
Table 6. COVID-19 Impact Global Market: (Four COPD Drug Delivery Devices Market Size Forecast Scenarios)
Table 7. Opportunities and Trends for COPD Drug Delivery Devices Players in the COVID-19 Landscape
Table 8. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 9. Key Regions/Countries Measures against Covid-19 Impact
Table 10. Proposal for COPD Drug Delivery Devices Players to Combat Covid-19 Impact
Table 11. Global COPD Drug Delivery Devices Market Size Growth Rate by Application 2020-2026 (K Units)
Table 12. Global COPD Drug Delivery Devices Market Size by Region in US$ Million: 2015 VS 2020 VS 2026
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global COPD Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in COPD Drug Delivery Devices as of 2019)
Table 15. COPD Drug Delivery Devices Manufacturing Base Distribution and Headquarters
Table 16. Manufacturers COPD Drug Delivery Devices Product Offered
Table 17. Date of Manufacturers Enter into COPD Drug Delivery Devices Market
Table 18. Key Trends for COPD Drug Delivery Devices Markets & Products
Table 19. Main Points Interviewed from Key COPD Drug Delivery Devices Players
Table 20. Global COPD Drug Delivery Devices Production Capacity by Manufacturers (2015-2020) (K Units)
Table 21. Global COPD Drug Delivery Devices Production Share by Manufacturers (2015-2020)
Table 22. COPD Drug Delivery Devices Revenue by Manufacturers (2015-2020) (Million US$)
Table 23. COPD Drug Delivery Devices Revenue Share by Manufacturers (2015-2020)
Table 24. COPD Drug Delivery Devices Price by Manufacturers 2015-2020 (US$/Unit)
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global COPD Drug Delivery Devices Production by Regions (2015-2020) (K Units)
Table 27. Global COPD Drug Delivery Devices Production Market Share by Regions (2015-2020)
Table 28. Global COPD Drug Delivery Devices Revenue by Regions (2015-2020) (US$ Million)
Table 29. Global COPD Drug Delivery Devices Revenue Market Share by Regions (2015-2020)
Table 30. Key COPD Drug Delivery Devices Players in North America
Table 31. Import & Export of COPD Drug Delivery Devices in North America (K Units)
Table 32. Key COPD Drug Delivery Devices Players in Europe
Table 33. Import & Export of COPD Drug Delivery Devices in Europe (K Units)
Table 34. Key COPD Drug Delivery Devices Players in China
Table 35. Import & Export of COPD Drug Delivery Devices in China (K Units)
Table 36. Key COPD Drug Delivery Devices Players in Japan
Table 37. Import & Export of COPD Drug Delivery Devices in Japan (K Units)
Table 38. Global COPD Drug Delivery Devices Consumption by Regions (2015-2020) (K Units)
Table 39. Global COPD Drug Delivery Devices Consumption Market Share by Regions (2015-2020)
Table 40. North America COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 41. North America COPD Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 42. Europe COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 43. Europe COPD Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 44. Asia Pacific COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 45. Asia Pacific COPD Drug Delivery Devices Consumption Market Share by Application (2015-2020) (K Units)
Table 46. Asia Pacific COPD Drug Delivery Devices Consumption by Regions (2015-2020) (K Units)
Table 47. Latin America COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 48. Latin America COPD Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 49. Middle East and Africa COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 50. Middle East and Africa COPD Drug Delivery Devices Consumption by Countries (2015-2020) (K Units)
Table 51. Global COPD Drug Delivery Devices Production by Type (2015-2020) (K Units)
Table 52. Global COPD Drug Delivery Devices Production Share by Type (2015-2020)
Table 53. Global COPD Drug Delivery Devices Revenue by Type (2015-2020) (Million US$)
Table 54. Global COPD Drug Delivery Devices Revenue Share by Type (2015-2020)
Table 55. COPD Drug Delivery Devices Price by Type 2015-2020 (US$/Unit)
Table 56. Global COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 57. Global COPD Drug Delivery Devices Consumption by Application (2015-2020) (K Units)
Table 58. Global COPD Drug Delivery Devices Consumption Share by Application (2015-2020)
Table 59. AstraZeneca Corporation Information
Table 60. AstraZeneca Description and Major Businesses
Table 61. AstraZeneca COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 62. AstraZeneca Product
Table 63. AstraZeneca Recent Development
Table 64. Boehringer Ingelheim GmbH Corporation Information
Table 65. Boehringer Ingelheim GmbH Description and Major Businesses
Table 66. Boehringer Ingelheim GmbH COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 67. Boehringer Ingelheim GmbH Product
Table 68. Boehringer Ingelheim GmbH Recent Development
Table 69. GlaxoSmithKline plc Corporation Information
Table 70. GlaxoSmithKline plc Description and Major Businesses
Table 71. GlaxoSmithKline plc COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 72. GlaxoSmithKline plc Product
Table 73. GlaxoSmithKline plc Recent Development
Table 74. Novartis AG Corporation Information
Table 75. Novartis AG Description and Major Businesses
Table 76. Novartis AG COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 77. Novartis AG Product
Table 78. Novartis AG Recent Development
Table 79. Teva Pharmaceutical Industries Corporation Information
Table 80. Teva Pharmaceutical Industries Description and Major Businesses
Table 81. Teva Pharmaceutical Industries COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 82. Teva Pharmaceutical Industries Product
Table 83. Teva Pharmaceutical Industries Recent Development
Table 84. Merck & Co., Inc. Corporation Information
Table 85. Merck & Co., Inc. Description and Major Businesses
Table 86. Merck & Co., Inc. COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 87. Merck & Co., Inc. Product
Table 88. Merck & Co., Inc. Recent Development
Table 89. Sunovion Pharmaceuticals, Inc. Corporation Information
Table 90. Sunovion Pharmaceuticals, Inc. Description and Major Businesses
Table 91. Sunovion Pharmaceuticals, Inc. COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 92. Sunovion Pharmaceuticals, Inc. Product
Table 93. Sunovion Pharmaceuticals, Inc. Recent Development
Table 94. Koninklijke Philips Corporation Information
Table 95. Koninklijke Philips Description and Major Businesses
Table 96. Koninklijke Philips COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 97. Koninklijke Philips Product
Table 98. Koninklijke Philips Recent Development
Table 99. Omron Corporation Corporation Information
Table 100. Omron Corporation Description and Major Businesses
Table 101. Omron Corporation COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 102. Omron Corporation Product
Table 103. Omron Corporation Recent Development
Table 104. Cipla Inc. Corporation Information
Table 105. Cipla Inc. Description and Major Businesses
Table 106. Cipla Inc. COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 107. Cipla Inc. Product
Table 108. Cipla Inc. Recent Development
Table 109. PARI GmbH Corporation Information
Table 110. PARI GmbH Description and Major Businesses
Table 111. PARI GmbH COPD Drug Delivery Devices Production (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2015-2020)
Table 112. PARI GmbH Product
Table 113. PARI GmbH Recent Development
Table 114. Global COPD Drug Delivery Devices Revenue Forecast by Region (2021-2026) (Million US$)
Table 115. Global COPD Drug Delivery Devices Production Forecast by Regions (2021-2026) (K Units)
Table 116. Global COPD Drug Delivery Devices Production Forecast by Type (2021-2026) (K Units)
Table 117. Global COPD Drug Delivery Devices Revenue Forecast by Type (2021-2026) (Million US$)
Table 118. North America COPD Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 119. Europe COPD Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 120. Asia Pacific COPD Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 121. Latin America COPD Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 122. Middle East and Africa COPD Drug Delivery Devices Consumption Forecast by Regions (2021-2026) (K Units)
Table 123. COPD Drug Delivery Devices Distributors List
Table 124. COPD Drug Delivery Devices Customers List
Table 125. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 126. Key Challenges
Table 127. Market Risks
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. COPD Drug Delivery Devices Product Picture
Figure 2. Global COPD Drug Delivery Devices Production Market Share by Type in 2020 & 2026
Figure 3. MDI Product Picture
Figure 4. DPI Product Picture
Figure 5. Global COPD Drug Delivery Devices Consumption Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. COPD Drug Delivery Devices Report Years Considered
Figure 10. Global COPD Drug Delivery Devices Revenue 2015-2026 (Million US$)
Figure 11. Global COPD Drug Delivery Devices Production Capacity 2015-2026 (K Units)
Figure 12. Global COPD Drug Delivery Devices Production 2015-2026 (K Units)
Figure 13. Global COPD Drug Delivery Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 14. COPD Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global COPD Drug Delivery Devices Production Share by Manufacturers in 2015
Figure 16. The Top 10 and Top 5 Players Market Share by COPD Drug Delivery Devices Revenue in 2019
Figure 17. Global COPD Drug Delivery Devices Production Market Share by Region (2015-2020)
Figure 18. COPD Drug Delivery Devices Production Growth Rate in North America (2015-2020) (K Units)
Figure 19. COPD Drug Delivery Devices Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 20. COPD Drug Delivery Devices Production Growth Rate in Europe (2015-2020) (K Units)
Figure 21. COPD Drug Delivery Devices Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 22. COPD Drug Delivery Devices Production Growth Rate in China (2015-2020) (K Units)
Figure 23. COPD Drug Delivery Devices Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 24. COPD Drug Delivery Devices Production Growth Rate in Japan (2015-2020) (K Units)
Figure 25. COPD Drug Delivery Devices Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 26. Global COPD Drug Delivery Devices Consumption Market Share by Regions 2015-2020
Figure 27. North America COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 28. North America COPD Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 29. North America COPD Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 30. U.S. COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. Canada COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Europe COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe COPD Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 34. Europe COPD Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 35. Germany COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. France COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. U.K. COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Italy COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Russia COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Asia Pacific COPD Drug Delivery Devices Consumption and Growth Rate (K Units)
Figure 41. Asia Pacific COPD Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 42. Asia Pacific COPD Drug Delivery Devices Consumption Market Share by Regions in 2019
Figure 43. China COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Japan COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. South Korea COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. India COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Australia COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Taiwan COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Indonesia COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Thailand COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Malaysia COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Philippines COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Vietnam COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Latin America COPD Drug Delivery Devices Consumption and Growth Rate (K Units)
Figure 55. Latin America COPD Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 56. Latin America COPD Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 57. Mexico COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Brazil COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Argentina COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Middle East and Africa COPD Drug Delivery Devices Consumption and Growth Rate (K Units)
Figure 61. Middle East and Africa COPD Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 62. Middle East and Africa COPD Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 63. Turkey COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Saudi Arabia COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. U.A.E COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Global COPD Drug Delivery Devices Production Market Share by Type (2015-2020)
Figure 67. Global COPD Drug Delivery Devices Production Market Share by Type in 2019
Figure 68. Global COPD Drug Delivery Devices Revenue Market Share by Type (2015-2020)
Figure 69. Global COPD Drug Delivery Devices Revenue Market Share by Type in 2019
Figure 70. Global COPD Drug Delivery Devices Production Market Share Forecast by Type (2021-2026)
Figure 71. Global COPD Drug Delivery Devices Revenue Market Share Forecast by Type (2021-2026)
Figure 72. Global COPD Drug Delivery Devices Market Share by Price Range (2015-2020)
Figure 73. Global COPD Drug Delivery Devices Consumption Market Share by Application (2015-2020)
Figure 74. Global COPD Drug Delivery Devices Value (Consumption) Market Share by Application (2015-2020)
Figure 75. Global COPD Drug Delivery Devices Consumption Market Share Forecast by Application (2021-2026)
Figure 76. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Sunovion Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Koninklijke Philips Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Omron Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Cipla Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. PARI GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Global COPD Drug Delivery Devices Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 88. Global COPD Drug Delivery Devices Revenue Market Share Forecast by Regions ((2021-2026))
Figure 89. Global COPD Drug Delivery Devices Production Forecast by Regions (2021-2026) (K Units)
Figure 90. North America COPD Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 91. North America COPD Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 92. Europe COPD Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 93. Europe COPD Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 94. China COPD Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 95. China COPD Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 96. Japan COPD Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 97. Japan COPD Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 98. Global COPD Drug Delivery Devices Consumption Market Share Forecast by Region (2021-2026)
Figure 99. COPD Drug Delivery Devices Value Chain
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Porter's Five Forces Analysis
Figure 103. Bottom-up and Top-down Approaches for This Report
Figure 104. Data Triangulation
Figure 105. Key Executives Interviewed
Figure 1. COPD Drug Delivery Devices Product Picture
Figure 2. Global COPD Drug Delivery Devices Production Market Share by Type in 2020 & 2026
Figure 3. MDI Product Picture
Figure 4. DPI Product Picture
Figure 5. Global COPD Drug Delivery Devices Consumption Market Share by Application in 2020 & 2026
Figure 6. Hospital
Figure 7. Clinic
Figure 8. Others
Figure 9. COPD Drug Delivery Devices Report Years Considered
Figure 10. Global COPD Drug Delivery Devices Revenue 2015-2026 (Million US$)
Figure 11. Global COPD Drug Delivery Devices Production Capacity 2015-2026 (K Units)
Figure 12. Global COPD Drug Delivery Devices Production 2015-2026 (K Units)
Figure 13. Global COPD Drug Delivery Devices Market Share Scenario by Region in Percentage: 2020 Versus 2026
Figure 14. COPD Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 15. Global COPD Drug Delivery Devices Production Share by Manufacturers in 2015
Figure 16. The Top 10 and Top 5 Players Market Share by COPD Drug Delivery Devices Revenue in 2019
Figure 17. Global COPD Drug Delivery Devices Production Market Share by Region (2015-2020)
Figure 18. COPD Drug Delivery Devices Production Growth Rate in North America (2015-2020) (K Units)
Figure 19. COPD Drug Delivery Devices Revenue Growth Rate in North America (2015-2020) (US$ Million)
Figure 20. COPD Drug Delivery Devices Production Growth Rate in Europe (2015-2020) (K Units)
Figure 21. COPD Drug Delivery Devices Revenue Growth Rate in Europe (2015-2020) (US$ Million)
Figure 22. COPD Drug Delivery Devices Production Growth Rate in China (2015-2020) (K Units)
Figure 23. COPD Drug Delivery Devices Revenue Growth Rate in China (2015-2020) (US$ Million)
Figure 24. COPD Drug Delivery Devices Production Growth Rate in Japan (2015-2020) (K Units)
Figure 25. COPD Drug Delivery Devices Revenue Growth Rate in Japan (2015-2020) (US$ Million)
Figure 26. Global COPD Drug Delivery Devices Consumption Market Share by Regions 2015-2020
Figure 27. North America COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 28. North America COPD Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 29. North America COPD Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 30. U.S. COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 31. Canada COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 32. Europe COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 33. Europe COPD Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 34. Europe COPD Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 35. Germany COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 36. France COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 37. U.K. COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 38. Italy COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 39. Russia COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 40. Asia Pacific COPD Drug Delivery Devices Consumption and Growth Rate (K Units)
Figure 41. Asia Pacific COPD Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 42. Asia Pacific COPD Drug Delivery Devices Consumption Market Share by Regions in 2019
Figure 43. China COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 44. Japan COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 45. South Korea COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 46. India COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 47. Australia COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 48. Taiwan COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 49. Indonesia COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 50. Thailand COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 51. Malaysia COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 52. Philippines COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 53. Vietnam COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 54. Latin America COPD Drug Delivery Devices Consumption and Growth Rate (K Units)
Figure 55. Latin America COPD Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 56. Latin America COPD Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 57. Mexico COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 58. Brazil COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 59. Argentina COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 60. Middle East and Africa COPD Drug Delivery Devices Consumption and Growth Rate (K Units)
Figure 61. Middle East and Africa COPD Drug Delivery Devices Consumption Market Share by Application in 2019
Figure 62. Middle East and Africa COPD Drug Delivery Devices Consumption Market Share by Countries in 2019
Figure 63. Turkey COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 64. Saudi Arabia COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 65. U.A.E COPD Drug Delivery Devices Consumption and Growth Rate (2015-2020) (K Units)
Figure 66. Global COPD Drug Delivery Devices Production Market Share by Type (2015-2020)
Figure 67. Global COPD Drug Delivery Devices Production Market Share by Type in 2019
Figure 68. Global COPD Drug Delivery Devices Revenue Market Share by Type (2015-2020)
Figure 69. Global COPD Drug Delivery Devices Revenue Market Share by Type in 2019
Figure 70. Global COPD Drug Delivery Devices Production Market Share Forecast by Type (2021-2026)
Figure 71. Global COPD Drug Delivery Devices Revenue Market Share Forecast by Type (2021-2026)
Figure 72. Global COPD Drug Delivery Devices Market Share by Price Range (2015-2020)
Figure 73. Global COPD Drug Delivery Devices Consumption Market Share by Application (2015-2020)
Figure 74. Global COPD Drug Delivery Devices Value (Consumption) Market Share by Application (2015-2020)
Figure 75. Global COPD Drug Delivery Devices Consumption Market Share Forecast by Application (2021-2026)
Figure 76. AstraZeneca Total Revenue (US$ Million): 2019 Compared with 2018
Figure 77. Boehringer Ingelheim GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 78. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 79. Novartis AG Total Revenue (US$ Million): 2019 Compared with 2018
Figure 80. Teva Pharmaceutical Industries Total Revenue (US$ Million): 2019 Compared with 2018
Figure 81. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 82. Sunovion Pharmaceuticals, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 83. Koninklijke Philips Total Revenue (US$ Million): 2019 Compared with 2018
Figure 84. Omron Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 85. Cipla Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 86. PARI GmbH Total Revenue (US$ Million): 2019 Compared with 2018
Figure 87. Global COPD Drug Delivery Devices Revenue Forecast by Regions (2021-2026) (US$ Million)
Figure 88. Global COPD Drug Delivery Devices Revenue Market Share Forecast by Regions ((2021-2026))
Figure 89. Global COPD Drug Delivery Devices Production Forecast by Regions (2021-2026) (K Units)
Figure 90. North America COPD Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 91. North America COPD Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 92. Europe COPD Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 93. Europe COPD Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 94. China COPD Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 95. China COPD Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 96. Japan COPD Drug Delivery Devices Production Forecast (2021-2026) (K Units)
Figure 97. Japan COPD Drug Delivery Devices Revenue Forecast (2021-2026) (US$ Million)
Figure 98. Global COPD Drug Delivery Devices Consumption Market Share Forecast by Region (2021-2026)
Figure 99. COPD Drug Delivery Devices Value Chain
Figure 100. Channels of Distribution
Figure 101. Distributors Profiles
Figure 102. Porter's Five Forces Analysis
Figure 103. Bottom-up and Top-down Approaches for This Report
Figure 104. Data Triangulation
Figure 105. Key Executives Interviewed
